6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Appendix 4C and Quarterly Activities Report - March 2026
9m ago	Landis+Gyr Announces Sale of Rhebo to Everfield
9m ago	Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
19m ago	2026 ESMO GC \| Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
31m ago	Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025

About

Amphastar P (NASDAQ:AMPH) — investor relations, events, news, and company updates on 6ix.

Latest News

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025

Amphastar Announces FDA Approval for Ipratropium Bromide HFA

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

Financials

Revenue

$719.89 M

Market Cap

$939.72 M

P/E Ratio

10.07

EPS

2.03

Community Chat

Ask AI